Clinically Bharat

We Can Cover You

Healthcare

Sanofi shares rise after update on MS drug trials, Health News, ET HealthWorld

Email :106

Paris: Sanofi shares rose by more than 2 per cent in early Paris stock market trading on Monday as the company updated investors on some of its ongoing trials for potential multiple sclerosis (MS) treatments.

The drugmaker said two Phase III trials showed that its experimental daily pill tolebrutinib was not better than its established MS drug Aubagio in reducing relapse rates in a highly common form of MS, while a separate late-stage trial showed the pill met the main goal to treat another form of MS.

Sanofi shares were up 2.5 per cent by 0710 GMT, making the stock the best performer on Paris’ benchmark CAC-40 equity index.

(Reporting by Tassilo Hummel; Editing by Sudip Kar-Gupta)

  • Published On Sep 2, 2024 at 02:38 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post